Vitamin D Binding Protein Alleles and Susceptibility for Type 1 Diabetes in Germans

References

• Yoon J. W., Tun H. S., Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 1998; 27: 109–122
   PubMed Web of Science ®Google Scholar
• Arnush M., Scarim A. L., Heitmeier M. R., Kelly C. B., Corbett J. A. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. Journal of Immunology 1998; 160: 2684–2691
   PubMed Web of Science ®Google Scholar
• Ridgway W. M., Fathman C. G. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clinical Immunology & Immunopathology 1998; 86: 3–10
   PubMedGoogle Scholar
• Marron M. P., Raffel L. J., Garchon H. J., Jacob O. C, Serrano-Rios M., Martinez L. M., Teng W. P., Park Y., Zhang Z. X., Goldstein D. R., Tao Y. W., Beaurain G., Bach J. F., Huang H. S., Luo D. F., Zeidler A., Rotter J. I., Yang M. C., Modilevsky T., Maclaren N. K., She J. X. Insulin-dependent diabetes mellitus (1DDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Human Molecular Genetics 1997; 6: 1275–1282
   PubMed Web of Science ®Google Scholar
• Pociot F., Ronningen K. S., Bergholdt R., Lorenzen T., Johannesen J., Ye K., Dinarello C. A., Nerup J. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes - evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood. Autoimmunity 1994; 19: 169–178
   PubMed Web of Science ®Google Scholar
• Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994; 37: 552–558
   PubMed Web of Science ®Google Scholar
• Jones G., Strugnell S. A., DeLuca H. F. Current understanding of the molecular actions of vitamin D. Physiology Reviews 1998; 78: 1193–1231
   PubMed Web of Science ®Google Scholar
• Szalhmary E. J. The effect of Gc genotype on fasting insulin level in Dogrib Indians. Human Genetics 1987; 75: 368–372
   PubMedGoogle Scholar
• Yamamoto N., Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophospha-tidylcholine-treated lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 8539–8543
   PubMed Web of Science ®Google Scholar
• Braun A., Bichlmaier R., Muller B., Cleve H. Molecular evaluation of an Alu repeat including a polymorphic variable poly(dA) (AluVpA) in the vitamin D binding protein (DBP) gene. Human Genetics 1993; 90: 526–532
   PubMed Web of Science ®Google Scholar
• Braun A., Bichlmaier R., Cleve H. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Human Genetics 1992; 89: 401–406
   PubMed Web of Science ®Google Scholar
• Cooke N. E., David E. V. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. Journal of Clinical Investigation 2420; 76: 2424, 1985
   Google Scholar
• Spielman R. S., McGinnis R. E., Ewens W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics 1993; 52: 506–516
   PubMed Web of Science ®Google Scholar
• Kamboh M. I., Ferrell R. E. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Human Genetics 1986; 72: 281–293
   PubMed Web of Science ®Google Scholar
• Cleve H., Patutschnick W., Nevo S., Wendt G. G. Genetic studies on the Gc subtypes. Human Genetics 1978; 44: 117–122
   PubMedGoogle Scholar
• Cleve H. The variants of the group-specific component. A review of their distribution in human populations. Israel Journal of Medical Science 1973; 9: 1133–1146
   PubMedGoogle Scholar
• Mein C. A., Esposito L., Dunn M. G., Johnson G. C., Timms A. E., Goy J. V., Smith A. N., Sebag-Montefiore L., Merriman M. E., Wilson A. J., Pritchard L. E., Cucca F., Barnett A. H., Bain S. C., Todd J. A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nature Genetics 1998; 19: 297–300
   PubMedGoogle Scholar
• Concannon P., Gogolin-Ewens K. J., Hinds D. A., Wapelhorst B., Morrison V. A., Stirling B., Mitra M., Farmer J., Williams S. R., Cox N. J., Bell G. I., Risch N., Spielman R. S. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nature Genetics 1998; 19: 292–296
   PubMed Web of Science ®Google Scholar
• Rigby W. F., Stacy T., Fanger M. W. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3. (calcitriol). Journal of Clinical Investigation 1984; 74: 1451–1455
   PubMed Web of Science ®Google Scholar
• Mauricio D., Mandrup-Poulsen T., Nerup J. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes-Metabolism Reviews 1996; 12: 57–68
   PubMedGoogle Scholar
• Thomasset M. Vitamin D and the immune system. Pathologic Biologic 1994; 42: 163–172
   PubMedGoogle Scholar
• Rigby W. F., Waugh M., Graziano R. F. Regulation of human monocyte HLA-DR and CD4 antigen expression and antigen presentation by 1,25-dihydroxyvitamin D3. Blood, Id 1990; 189–197
   Google Scholar
• Haddad G. J. Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. Journal of Steroid Biochemistry & Molecular Biology 1995; 53: 579–582
   PubMed Web of Science ®Google Scholar
• Piquette C. A., Robinson-Hill R., Webster R. O. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. Journal of Leukocyte Biology 1994; 55: 349–354
   PubMed Web of Science ®Google Scholar
• Braun A., Brandhofer A., Cleve H. Interaction of the vitamin D-binding protein (group-specific component) and its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusing. Electrophoresis 1990; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Kew R. R., Sibug M. A., Liuzzo J. P., Webster R. O. Localization and quantitation of the vitamin D binding protein (Gc-globulin) in human neutrophils. Blood 1993; 82: 274–283
   PubMed Web of Science ®Google Scholar
• Yamamoto N., Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. Journal of Immmunology 1993; 151: 2794–2802
   PubMed Web of Science ®Google Scholar
• Naraparaju V. R., Yamamoto N. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunology Letter 1994; 43: 143–148
   PubMedGoogle Scholar
• Arnaud J., Conslans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Human Genetics 1993; 92: 183–188
   PubMed Web of Science ®Google Scholar
• Kumar R. The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. Kidney International 1986; 30: 793–803
   PubMed Web of Science ®Google Scholar
• Bouillon R., Van Assche F. A., Van Baelen H., Heyns W., De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1.25- dihydroxyvitamin D3 concentration. Journal of Clinical Investigation 1981; 67: 589–596
   PubMed Web of Science ®Google Scholar
• Hollsberg P., Haahr S., Larsen P. M., Fey S. J. MS and the group-specific component. Acta Neurologica Scandinavial 1988; 78: 158–160
   PubMed Web of Science ®Google Scholar
• Lindbiom B., Wetterling G., Link H. Distribution of group-specific component subtypes in multiple sclerosis. Acta Neurological Scundinarica 1988; 78: 443–444
   PubMedGoogle Scholar
• Ogata M., Iwasaki M., Kubo S., Nakasono I., Suyama H., Kinoshita K., Ikeda S., Momida S., Ichimaru M. Serum Gc, Hp and alpha 2HS phenotypes in human T-lymphotropic leukemia virus type I infection. Human Heredity 1990; 40: 253–256
   PubMedGoogle Scholar
• Baier L. J., Dobberfuhl A. M., Pratley R. E., Hanson R. L., Bogardus C. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabelic Pima Indians. journal of Clinical Endocrinology & Metbolism 1998; 83: 2993–2996
   PubMed Web of Science ®Google Scholar
• Papiha S. S., Pal B. Gc (vitamin D binding protein) subtypes in rheumatoid arthritis. Human Genetics 1985; 70: 278–280
   PubMedGoogle Scholar
• Schellenberg D., Pare P. D., Weir T. D., Spinelli J. J., Walker B. A., Sandford A. J. Vilamin D binding protein variants and the risk of COPD. American Journal of Respiratory & Critical Care Medicine 1998; 157: 957–961
   PubMed Web of Science ®Google Scholar